RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.95B
1-Year Est. Return 81.42%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+81.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.71B
AUM Growth
+$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
101
New
Increased
Reduced
Closed

Top Buys

1
+$8.04M
2
+$7.36M
3
+$5.6M
4
TVTX icon
Travere Therapeutics
TVTX
+$4.82M
5
BBIO icon
BridgeBio Pharma
BBIO
+$4.15M

Top Sells

1
+$30.4M
2
+$23.8M
3
+$21.8M
4
INSM icon
Insmed
INSM
+$17.2M
5
UNH icon
UnitedHealth
UNH
+$15.8M

Sector Composition

1 Healthcare 98.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS icon
76
Apellis Pharmaceuticals
APLS
$2.68B
$2.08M 0.12%
92,000
+7,700
NGNE icon
77
Neurogene
NGNE
$364M
$1.81M 0.11%
104,339
KRRO icon
78
Korro Bio
KRRO
$114M
$1.71M 0.1%
35,719
CNTA
79
Centessa Pharmaceuticals
CNTA
$3.97B
$1.68M 0.1%
+69,240
CATX icon
80
Perspective Therapeutics
CATX
$615M
$1.52M 0.09%
444,383
APLT
81
DELISTED
Applied Therapeutics
APLT
$1.26M 0.07%
2,075,991
MRSN
82
DELISTED
Mersana Therapeutics
MRSN
$1.18M 0.07%
152,586
-1
IMVT icon
83
Immunovant
IMVT
$5.64B
$1.18M 0.07%
72,965
-148,535
EYPT icon
84
EyePoint Inc
EYPT
$1.45B
$451K 0.03%
+31,655
CRL icon
85
Charles River Laboratories
CRL
$8.78B
$422K 0.02%
2,700
PCVX icon
86
Vaxcyte
PCVX
$8.86B
$400K 0.02%
11,100
NVAX icon
87
Novavax
NVAX
$1.65B
$390K 0.02%
45,000
-8,900
PRTA icon
88
Prothena Corp
PRTA
$467M
$248K 0.01%
25,398
-467,203
MLTX icon
89
MoonLake Immunotherapeutics
MLTX
$1.24B
$202K 0.01%
+28,200
NUVB.WS
90
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$27.1K ﹤0.01%
134,028
CGEN icon
91
Compugen
CGEN
$169M
$19.7K ﹤0.01%
13,430
-976,560
CGEM icon
92
Cullinan Oncology
CGEM
$916M
– –
-668,233
ETNB
93
DELISTED
89bio
ETNB
– –
-40,000
LUNG icon
94
Pulmonx
LUNG
$65.2M
– –
-651,100
NUVL icon
95
Nuvalent
NUVL
$7.92B
– –
-93,328
OSCR icon
96
Oscar Health
OSCR
$4.06B
– –
-700,000
SRPT icon
97
Sarepta Therapeutics
SRPT
$1.76B
– –
-68,600
UNH icon
98
UnitedHealth
UNH
$266B
– –
-50,500
ADAP
99
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-2,483,468
BPMC
100
DELISTED
Blueprint Medicines
BPMC
– –
-185,500
1 2 3
4